The current status of targeting BAFF/BLyS for autoimmune diseases

Arthritis Research & Therapy
Meera Ramanujam, Anne Davidson

Abstract

It is increasingly recognized that B cells have multiple functions that contribute to the pathogenesis of autoimmunity. Specific targeting of B cells might therefore be an appropriate therapeutic intervention. The tumor necrosis factor-like molecule BAFF (BLyS) is a key B cell survival factor and its receptors are expressed on most peripheral B cells. Several different BAFF antagonists are under development and in early clinical trials. We review here the rationale for BAFF blockade, and its predicted mechanism of action in autoimmune diseases.

References

Dec 10, 1999·The Journal of Experimental Medicine·F MackayJ L Browning
Oct 4, 2000·The Journal of Experimental Medicine·R K DoS Chen-Kiang
Sep 6, 2001·European Journal of Immunology·G CasseseR A Manz
Jan 10, 2002·The Journal of Clinical Investigation·Joanna GroomFabienne Mackay
Jun 19, 2002·The Journal of Clinical Investigation·Jens V SteinMichael Hahne
Aug 3, 2002·Nature Immunology·Mikhail B LitinskiyAndrea Cerutti
Nov 13, 2002·Annual Review of Immunology·Fabienne MackayJeffrey Browning
Feb 5, 2003·The Journal of Experimental Medicine·Patrizia ScapiniMarco A Cassatella
Jun 11, 2003·The Journal of Biological Chemistry·Marc PelletierYen-Ming Hsu
Jul 17, 2003·The Journal of Clinical Investigation·Danielle T AveryStuart G Tangye
Sep 17, 2003·The Journal of Experimental Medicine·Leonid GorelikMartin L Scott
Oct 14, 2003·Biochemical Pharmacology·Geertruida M KolfschotenJan Paul Medema
Oct 15, 2003·The Journal of Experimental Medicine·Ziaur S M RahmanTim Manser
Jan 7, 2004·The Journal of Experimental Medicine·Brian P O'ConnorRandolph J Noelle
Jan 20, 2004·Molecular and Cellular Biology·Eugene VarfolomeevAvi Ashkenazi
Feb 7, 2004·The Journal of Biological Chemistry·Darshana R PatelRobert F Kelley
Feb 14, 2004·Immunological Reviews·Michael P Cancro
Feb 24, 2004·International Immunology·Bertrand HuardLars E French
May 15, 2004·Immunity·Flavius Martin, Andrew C Chan

❮ Previous
Next ❯

Citations

Apr 21, 2006·Applied Microbiology and Biotechnology·Peng CaoYunlong Hu
Apr 23, 2008·Applied Microbiology and Biotechnology·Meng CaoShuangquan Zhang
Oct 8, 2008·Apoptosis : an International Journal on Programmed Cell Death·Sherif F TadrosRobert D Frisina
Dec 23, 2008·Applied Biochemistry and Biotechnology·Meng CaoShuangquan Zhang
Nov 10, 2007·Clinical Reviews in Allergy & Immunology·Jiska M MeijerCees G M Kallenberg
Jan 22, 2008·Expert Reviews in Molecular Medicine·Meera Ramanujam, Anne Davidson
Feb 18, 2006·The Journal of Clinical Investigation·Meera RamanujamAnne Davidson
Oct 25, 2008·Arthritis Research & Therapy·Stacy P Ardoin, David S Pisetsky
May 11, 2010·PLoS Neglected Tropical Diseases·Daniela A BermejoAdriana Gruppi
Nov 25, 2005·Scandinavian Journal of Immunology·P Szodoray, R Jonsson
Jun 14, 2005·Expert Opinion on Therapeutic Targets·Yong Wook ParkCornelia M Weyand
Apr 2, 2009·Diabetes·Eliana MariñoShane T Grey
Jan 26, 2007·Journal of Dermatological Science·R WatanabeK Tamaki
Dec 17, 2005·Journal of Clinical Rheumatology : Practical Reports on Rheumatic & Musculoskeletal Diseases·Mark C Genovese
Sep 2, 2008·Arthritis and Rheumatism·Philip KahnAnne Davidson
May 20, 2006·The Journal of Immunology : Official Journal of the American Association of Immunologists·Juli P MillerMichael P Cancro

❮ Previous
Next ❯

Related Concepts

Related Feeds

Autoimmune Diseases

Autoimmune diseases occur as a result of an attack by the immune system on the body’s own tissues resulting in damage and dysfunction. There are different types of autoimmune diseases, in which there is a complex and unknown interaction between genetics and the environment. Discover the latest research on autoimmune diseases here.